Clozapine Induced Hypertension and its Association with Autonomic Dysfunction
- PMID: 34887604
- PMCID: PMC8601757
- DOI: 10.64719/pb.4423
Clozapine Induced Hypertension and its Association with Autonomic Dysfunction
Abstract
Clozapine is a second generation antipsychotic agent which is drug of choice for treatment resistant schizophrenia. Tachycardia and postural hypotension are most frequently observed cardiovascular adverse effects, but reports on new-onset persistently elevated blood pressure are sparse. Mechanisms underlying clozapine induced hypertension also remain unclear. We report the case of a 32 year old normotensive male with persistently elevated systolic and diastolic blood pressure after clozapine initiation. Hypertension persisted throughout the phase of dose optimization and dose stabilization at 300 mg/day, requiring an addition of a beta blocker (atenolol) after a month of observation. The 24 hour urinary catecholamines were within normal limits. Autonomic function tests revealed severe loss of parasympathetic activity and cardiac autonomic tone. The case adds to limited information on autonomic dysfunction as a potential factor in clozapine induced hypertension.
Keywords: adverse effects; clozapine; hypertension.
Copyright © 1964–2021 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
Figures
References
-
- Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry . 1988;45:789–796. - PubMed
-
- Hoorn EJ, van der Poel MF. Hypokalemic hypertension related to clozapine: a case report. J Clin Psychopharmacol . 2014;34:390–392. - PubMed
-
- Visscher AJ, Cohen D. Periorbital oedema and treatment-resistant hypertension as rare side effects of clozapine. Aust N Z J Psychiatry . 2011;45:1097–1098. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
